DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Bertotti A. et al.
A molecularly annotated platform of patient-derived xenografts (“xenopatients”) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer.

Cancer Discov 2011;
1: 508-523

Download Bibliographical Data

Search in:
Access: